Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Mussai P"'
Autor:
Nicola Fenwick, Rebekah Weston, Keith Wheatley, Jodie Hodgson, Lynley Marshall, Martin Elliott, Guy Makin, Antony Ng, Bernadette Brennan, Stephen Lowis, Jenny Adamski, John Paul Kilday, Rachel Cox, Mike Gattens, Andrew Moore, Toby Trahair, Milind Ronghe, Martin Campbell, Helen Campbell, Molly W. Williams, Maria Kirby, Natasha Van Eijkelenburg, Jennifer Keely, Ugo Scarpa, Victoria Stavrou, Livingstone Fultang, Sarah Booth, Paul Cheng, Carmela De Santo, Francis Mussai
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe survival for many children with relapsed/refractory cancers remains poor despite advances in therapies. Arginine metabolism plays a key role in the pathophysiology of a number of pediatric cancers. We report the first in child study of
Externí odkaz:
https://doaj.org/article/4902b15b11094343be86c12a848d2cb8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Marine Drugs, Vol 21, Iss 4, p 216 (2023)
Microalgae are unicellular organisms and commonly present in the euphotic zone of marine ecosystems. From the western coast of Mauritius, three strains of Prorocentrum species were isolated from macrophytes and cultured under standard laboratory cond
Externí odkaz:
https://doaj.org/article/c3ab47d4b89149efaaba8faffa55f350
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ebtehag Maneta, Livingstone Fultang, Jemma Taylor, Matthew Pugh, William Jenkinson, Graham Anderson, Arri Coomarasamy, Mark D Kilby, David M Lissauer, Francis Mussai, Carmela De Santo
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 5, Pp n/a-n/a (2022)
Abstract Objectives Recombinant granulocyte colony‐stimulating factor (G‐CSF) is frequently administered to patients with cancer to enhance granulocyte recovery post‐chemotherapy. Clinical trials have also used G‐CSF to modulate myeloid cell
Externí odkaz:
https://doaj.org/article/0414cf0613b5453ea25dba6c33186ee0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Livingstone Fultang, Silvia Panetti, Margaret Ng, Paul Collins, Suzanne Graef, Nagy Rizkalla, Sarah Booth, Richard Lenton, Boris Noyvert, Claire Shannon-Lowe, Gary Middleton, Francis Mussai, Carmela De Santo
Publikováno v:
EBioMedicine, Vol 47, Iss , Pp 235-246 (2019)
Background: Targeting of MDSCs is a major clinical challenge in the era of immunotherapy. Antibodies which deplete MDSCs in murine models can reactivate T cell responses. In humans such approaches have not developed due to difficulties in identifying
Externí odkaz:
https://doaj.org/article/4484df2a46f841cf91fd257440db08ae
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Tumor cells require a higher supply of nutrients for growth and proliferation than normal cells. It is well established that metabolic reprograming in cancers for increased nutrient supply exposes a host of targetable vulnerabilities. In this article
Externí odkaz:
https://doaj.org/article/df47f1418fea4ca09c19f3485f2950f0
Autor:
Eleanor Brindle, Lorraine Lillis, Rebecca Barney, Pooja Bansil, Sonja Y. Hess, K. Ryan Wessells, Césaire T. Ouédraogo, Francisco Arredondo, Mikaela K. Barker, Neal E. Craft, Christina Fischer, James L. Graham, Peter J. Havel, Crystal D. Karakochuk, Mindy Zhang, Ei-Xia Mussai, Carine Mapango, Jody M. Randolph, Katherine Wander, Christine M. Pfeiffer, Eileen Murphy, David S. Boyle
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
A lack of comparative data across laboratories is often a barrier to the uptake and adoption of new technologies. Furthermore, data generated by different immunoassay methods may be incomparable due to a lack of harmonization. In this multicenter stu
Externí odkaz:
https://doaj.org/article/235b3cba36f74d68940cc5e82c48881a
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-5 (2018)
Abstract Background Metastatic melanoma is an aggressive skin cancer with a poor prognosis. Current treatment strategies for high-stage melanoma are based around the use of immunotherapy with immune checkpoint inhibitors such as anti-PDL1 or anti-CTL
Externí odkaz:
https://doaj.org/article/f530e5020b444328b180cb986d30f385